Concepedia
Statistics
Publications
9
Citations
1K
H-Index
Active since
1969
Affiliations
Eli Lilly (United States)(Current)
Wood Hudson Cancer Research Laboratory
University of Cincinnati
St. Elizabeth Healthcare
Larry E. Douglass is an author at Eli Lilly (United States) specializing in medicine, tumor biology, and tumor microenvironment.
Top concepts
MedicineTumor BiologyOncologyPathologyCell BiologyCancer BiologyCancer ResearchTumor MicroenvironmentUrologyImmunology
Publications per year
1969–2018
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent et al. · Journal of Clinical Investigation · 2007 · 375 citations · Full text
Tumor Biology, Therapeutic Suppression, Medicine +12
eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch et al. · Cancer Research · 2009 · 197 citations
Eif4e Activation, Urology, Genitourinary Cancer +11
Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis
Julia H. Carter, Larry E. Douglass, James A. Deddens et al. · Clinical Cancer Research · 2004 · 179 citations
Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam
David R. Weber, Larry E. Douglass, William G. Brundage et al. · The American Journal of Medicine · 1969 · 61 citations
Acute Varieties, Pathology, U. S. Soldiers +2
Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma
Julia H. Carter, James A. Deddens, Nelson Reed Spaulding et al. · British Journal of Cancer · 2016 · 53 citations · Full text
1–5 of 9